[1] |
Luo Nan, Li Rongkuan.
Spontaneous bacterial peritonitis in patients with liver cirrhosis
[J]. Journal of Practical Hepatology, 2022, 25(5): 616-619.
|
[2] |
Mi Meng,Lu Bingjiu,Wang Xueliang, et al..
Analysis of blood lipid in patients with metabolism-related fatty liver diseases
[J]. Journal of Practical Hepatology, 2022, 25(5): 653-656.
|
[3] |
Liu Yantong, Yao Yang, Lu Bo.
Short-term efficacy of Heye Tiaozhi Shugan Decoction in dealing with patients with nonalcoholic fatty liver diseases
[J]. Journal of Practical Hepatology, 2022, 25(5): 657-660.
|
[4] |
Xi Jiaying, Tang Jiamei, Liu Lingyu, et al..
Evaluation of left ventricular functions by three-dimensional speckle tracking imaging in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus
[J]. Journal of Practical Hepatology, 2022, 25(5): 661-664.
|
[5] |
Luo Suyan, Li Tingting, Wang Yaqi,et al..
Diagnostic performance of peripheral blood Treg/Th17 cells and their related cytokines in predicting significant liver fibrosis in patients with primary biliary cholangitis
[J]. Journal of Practical Hepatology, 2022, 25(5): 673-676.
|
[6] |
Gong Hao, Huang Li, Zhang Qinghong, et al..
Diagnostic efficacy of urine microalbumin, β2-microglobulin and N-acetyl-beta-glucosaminidase levels for renal injury in patients with decompensated liver cirrhosis
[J]. Journal of Practical Hepatology, 2022, 25(5): 681-684.
|
[7] |
Huang Juan, Zhang Jichen.
MRI LAVA scanning for collateral circulation in patients with Budd-Chiari syndrome
[J]. Journal of Practical Hepatology, 2022, 25(5): 689-692.
|
[8] |
Shi Ying, Bai Genji,Sun Yang.
Diagnostic performance of multimodal MRI in differentiating dysplastic nodules and small hepatocellular carcinoma in patients with liver cirrhosis
[J]. Journal of Practical Hepatology, 2022, 25(5): 722-725.
|
[9] |
Yang Jing, Cheng Yanli.
Idiopathic non-cirrhotic portal hypertension: one case report and literature review
[J]. Journal of Practical Hepatology, 2022, 25(5): 750-752.
|
[10] |
Chronic Disease Management Branch, China Pharmaceutical Biotechnology Association.
Expert consensus on the management of diabetes mellitus in patients with liver cirrhosis
[J]. Journal of Practical Hepatology, 2022, 25(5): 0-S1.
|
[11] |
Wang Qing, Zhang Lili.
When T2DM comes across with NAFLD:1+1>2?
[J]. Journal of Practical Hepatology, 2022, 25(4): 460-463.
|
[12] |
Wang Xiaoyan, Zhong Xueyu, Wu Chunyan.
Impact of saxagliptin on AMPK/mTOR-TFEB autophagy signaling pathway in rats with non-alcoholic fatty liver disease and concomitant type 2 diabetes mellitus
[J]. Journal of Practical Hepatology, 2022, 25(4): 476-479.
|
[13] |
Mo Jinying, Yu Xi, Yu Xueping, et al.
Diagnostic performance of FibroTouch scan in identifying liver fibrosis in hepatitis B virus carriers
[J]. Journal of Practical Hepatology, 2022, 25(4): 480-483.
|
[14] |
Luo Zhenzhen, Tian Haiying, Ge Jianhua, et al.
Clinical evaluation of liver fibrosis by serum N-oligosaccharide and bile acid levels and liver stiffness measurement combination in patients with chronic hepatitis C
[J]. Journal of Practical Hepatology, 2022, 25(4): 504-507.
|
[15] |
Fu Lihong, Gao Yueqiu, Wang XiaoLin, et al.
Liver pathological features of patients with drug-induced liver injury: An analysis of 38 cases
[J]. Journal of Practical Hepatology, 2022, 25(4): 512-516.
|